CHURCH & DWIGHT CO INC /DE/

(CHD)

CIK 313927 · SEC filings only

Not yet gradedBuyback record
harness minimum not met
company entity
3 resolved promises

Not enough resolved promises to grade

3 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro

Credibility timeline

KEPT · Feb 21, 2019KEPT · Feb 18, 2020PARTIAL · Feb 15, 2024
20192024
Timeline as a list
  • Feb 21, 2019KEPTThe Board of Directors has authorized a new program under which up to $500 million of the Company's common stock may be repurchased in the future
  • Feb 18, 2020KEPTup to $500 million of the Company's common stock may be repurchased
  • Feb 15, 2024PARTIALthe Board of Directors authorized a new stock repurchase program under which up to $1 billion of the Company's common stock may be repurchased
3 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
BGuidance record
grade
company entity
23 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro

Guidance shown, not graded (77)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance fy · May 1, 2026
    Our Adjusted EPS expectation for 2026 remains at 5% to 8% growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · May 1, 2026
    We continue to expect full-year reported EPS to increase approximately 18% to 22%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance q · May 1, 2026
    expected Adjusted EPS of $0.88 per share for the quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Oct 31, 2025
    We expect full year Adjusted EPS growth for 2025 of approximately $3.49
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance q · Oct 31, 2025
    we expect Adjusted EPS of approximately $0.83 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. revenue guidance q · Oct 31, 2025
    organic sales growth of approximately 1.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. revenue guidance fy · Oct 31, 2025
    We remain on track to deliver 2025 organic sales growth of approximately 1%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Aug 1, 2025
    We continue to expect full year Adjusted EPS growth for 2025 of 0 to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance q · Aug 1, 2025
    we expect Adjusted EPS of $0.72 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance q · May 1, 2025
    we expect Adjusted EPS of $0.85 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · May 1, 2025
    We now expect full year adjusted EPS growth for 2025 of 0% to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. revenue guidance fy · May 1, 2025
    We now expect organic sales growth of approximately 0% to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. revenue guidance q · May 1, 2025
    For Q2, we expect organic sales of approximately -2% to Flat
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Jan 31, 2025
    Our Adjusted EPS expectation for 2025 is 7% to 8% growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance q · Jan 31, 2025
    we expect Adjusted EPS of $0.90 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Jan 31, 2025
    $ 3.63 to 3.67
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance q · Nov 1, 2024
    we expect reported EPS of $0.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Nov 1, 2024
    We continue to expect full year adjusted EPS growth to be approximately 8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance q · Nov 1, 2024
    Adjusted EPS of $0.76 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance q · May 2, 2024
    Adjusted EPS of $0.83 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · May 2, 2024
    Our full year reported EPS growth is expected to be approximately +9.5-10.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance q · May 2, 2024
    we expect reported EPS of $0.81
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · May 2, 2024
    our Adjusted EPS growth expectation is now 8-9%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Feb 2, 2024
    Our Adjusted EPS expectation for 2024 is 7-9% growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance q · Feb 2, 2024
    we expect Adjusted EPS of $0.85 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance q · Nov 3, 2023
    we expect Reported EPS of $0.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance q · Nov 3, 2023
    Adjusted EPS of $0.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Nov 3, 2023
    We continue to expect Reported EPS to be $3.03
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · Nov 3, 2023
    Adjusted EPS to be $3.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance q · Jul 28, 2023
    Adjusted EPS of $0.66
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance q · Jul 28, 2023
    we expect Reported EPS of $0.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance fy · Jul 28, 2023
    Adjusted EPS to be $3.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance fy · Jul 28, 2023
    We now expect Reported EPS to be $3.03
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. eps guidance q · Apr 27, 2023
    we expect Adjusted EPS of $0.78
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance fy · Apr 27, 2023
    Diluted Earnings Per Share - Reported $ 2.91 to 2.97
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance q · Apr 27, 2023
    Reported EPS is expected to be $0.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance fy · Apr 27, 2023
    Diluted Earnings Per Share - Adjusted (non-GAAP) $ 3.03 to 3.09
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Feb 3, 2023
    Our Adjusted EPS expectation for 2023 is 0-4% growth.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance q · Feb 3, 2023
    we expect Adjusted EPS of $0.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Oct 28, 2022
    We now expect adjusted EPS to be in the range of $2.93-$2.97
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. eps guidance q · Oct 28, 2022
    We expect adjusted EPS of $0.58-$0.62
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  42. eps guidance fy · Apr 28, 2022
    we now expect EPS to be at 4%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance q · Apr 28, 2022
    we expect EPS of $0.70 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  44. eps guidance q · Oct 29, 2021
    Adjusted EPS is expected to be $0.61 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  45. eps guidance fy · Oct 29, 2021
    We expect full year 2021 adjusted EPS growth of 6%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  46. eps guidance q · Apr 29, 2021
    Adjusted EPS is expected to be $0.69 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  47. eps guidance fy · Apr 29, 2021
    We continue to expect 2021 to be another strong year with adjusted EPS of $3.00 to $3.06
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  48. eps guidance q · Oct 29, 2020
    we expect Q4 EPS to be $0.50-$0.52 per share excluding the acquisition earn-out adjustment
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  49. eps guidance fy · Oct 29, 2020
    we now expect adjusted EPS growth to be $2.79 to $2.81
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  50. eps guidance fy · Jul 31, 2020
    Adjusted EPS growth is expected to be 13%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  51. eps guidance fy · Jan 31, 2020
    We expect 2020 to be another strong year with adjusted EPS of $2.64 to $2.69
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  52. eps guidance q · Jan 31, 2020
    adjusted EPS to be $0.73 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  53. eps guidance q · Jul 31, 2019
    We expect adjusted EPS to be $0.60 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  54. eps guidance fy · Jul 31, 2019
    We expect to achieve $2.47 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  55. eps guidance fy · May 2, 2019
    We continue to expect 2019 adjusted EPS of $2.43 to $2.47
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  56. eps guidance q · May 2, 2019
    We expect adjusted EPS to be $0.52 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  57. eps guidance fy · Feb 5, 2019
    We expect 2019 to be another strong year with EPS of $2.43 to $2.47
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  58. eps guidance q · Feb 5, 2019
    For Q1, we expect reported and organic sales growth of approximately 3.5% to 4% and EPS to be $0.66 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  59. eps guidance fy · Nov 1, 2018
    Our 2018 EPS outlook is $2.27
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  60. eps guidance q · Nov 1, 2018
    We expect EPS to be $0.57 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  61. eps guidance q · May 3, 2018
    We expect EPS to approximate $0.46 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  62. eps guidance fy · May 3, 2018
    2018 EPS Outlook: $2.24 to $2.28
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  63. eps guidance fy · Nov 2, 2017
    EPS is expected to be $1.82 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  64. eps guidance fy · Nov 2, 2017
    we expect to achieve $1.92 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  65. eps guidance q · Nov 2, 2017
    We expect EPS of $0.50 in the fourth quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  66. eps guidance fy · May 4, 2017
    On a reported basis, EPS is expected to be $1.75 to $1.77 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  67. eps guidance fy · May 4, 2017
    we expect to achieve 8.5% adjusted EPS growth or $1.92 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  68. eps guidance q · May 4, 2017
    adjusted of $0.37 per share in the second quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  69. eps guidance q · May 4, 2017
    We expect reported EPS of $0.21 to $0.23
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  70. eps guidance fy · Nov 3, 2016
    we expect to achieve high single digit EPS growth in 2017
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  71. eps guidance q · Nov 3, 2016
    EPS is expected to be $0.42
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  72. eps guidance fy · Nov 3, 2016
    We are tightening our EPS growth at the lower end of our previous range of 14-15% reported and 8-9% adjusted to 14% and 8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  73. eps guidance q · Aug 4, 2016
    Reported EPS is expected to be $0.92
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  74. eps guidance fy · Aug 4, 2016
    We now expect 14 to 15% reported and 8 to 9% adjusted EPS growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  75. eps guidance fy · Feb 2, 2016
    We expect to achieve 7 to 9% adjusted EPS growth.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  76. eps guidance q · Feb 2, 2016
    earnings per share of $0.83
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  77. eps guidance q · Feb 2, 2016
    On an adjusted basis, EPS is expected to be $0.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (8) · 18 superseded

Open · revenue guidance q

For the first quarter, we expect organic sales growth of approximately 2-3%

unresolved — no outcome on filereceipt
Open · revenue guidance fy

We now expect reported and organic sales growth at the lower end of our 3-4% range for the total Company

unresolved — no outcome on filereceipt
Open · revenue guidance q

expect reported and organic sales growth of approximately 1-2%

unresolved — no outcome on filereceipt
Open · revenue guidance q

we expect reported sales growth of approximately 12%

unresolved — no outcome on file$12.0000receipt
Open · revenue guidance fy

We expect reported sales growth of approximately 7%

unresolved — no outcome on file$7.0000receipt
Open · revenue guidance fy

organic sales growth to be approximately 4%

unresolved — no outcome on filereceipt
Open · revenue guidance q

we expect reported sales growth of approximately 6.5%

unresolved — no outcome on file$6.5000receipt
Open · revenue guidance fy

We continue to expect reported sales to decline approximately 1.5% to 0.5%

resolves in ~202 daysreceipt
Superseded · revenue guidance fy

We expect 2025 reported sales growth of approximately 0 to 2%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We now expect full year 2019 reported sales growth of approximately 5-6%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We now expect full year 2023 reported sales growth to be approximately 6-7%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We now expect full year 2021 reported sales growth to be 5-6%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We now expect full year 2023 reported sales growth to be approximately 8%

revised by a later guidance$8.0000receipt
Superseded · revenue guidance fy

We continue to expect reported and organic sales growth of approximately 3-4%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We now expect approximately 9-10% full year 2020 sales growth

revised by a later guidancereceipt
Superseded · revenue guidance fy

We now expect sales growth to be 9%

revised by a later guidancereceipt
Superseded · revenue guidance fy

In 2025 we expect reported sales growth of approximately of 2.5% to 3.5%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We expect full year 2019 sales growth to be approximately 3.5%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We expect organic sales growth of approximately 3%

revised by a later guidance$3.0000receipt
Superseded · revenue guidance fy

organic sales growth to be approximately 3.5%

revised by a later guidance$3.5000receipt
Superseded · revenue guidance fy

We continue to expect full year 2024 reported and organic sales growth to be approximately 4 to 5%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We continue to expect full year 2022 reported sales growth to be approximately 5% to 8%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We expect reported and organic sales growth of approximately 3%

revised by a later guidancereceipt
Superseded · revenue guidance fy

In 2024 we expect full year reported and organic sales growth to be approximately 4-5%

revised by a later guidancereceipt
Superseded · revenue guidance fy

In 2023, we expect full year reported sales growth to be approximately 5-7%

revised by a later guidancereceipt
Superseded · revenue guidance fy

We expect full year 2020 reported sales growth to be approximately 6.5%

revised by a later guidance$6.5000receipt

Credibility timeline

UNRESOLVABLE · May 3, 2018UNRESOLVABLE · Nov 1, 2018BEAT · Feb 16, 2023BEAT · Feb 16, 2023KEPT · Apr 27, 2023BEAT · Feb 15, 2024KEPT · Feb 15, 2024KEPT · Feb 13, 2025BEAT · Feb 13, 2025MISSED · May 1, 2025BEAT · Oct 31, 2025BEAT · Feb 12, 2026BEAT · Feb 12, 2026KEPT · Jul 31, 2026
20182026
Timeline as a list
  • May 3, 2018UNRESOLVABLEwe expect reported sales growth of 12%
  • Nov 1, 2018UNRESOLVABLEWe now expect full year 2018 sales growth to exceed 9%
  • Feb 16, 2023BEATWe continue to expect full year 2022 reported sales growth to be approximately 3%
  • Feb 16, 2023BEATin Q4, we expect reported sales growth of approximately 2%
  • Apr 27, 2023KEPTFor Q1, we expect reported sales growth of approximately 4%
  • Feb 15, 2024BEATFor Q4, we expect reported sales growth of approximately 5%
  • Feb 15, 2024KEPTWe now expect full year 2023 reported sales growth to be approximately 9%
  • Feb 13, 2025KEPTWe continue to expect full year reported sales to be approximately 3.5%
  • Feb 13, 2025BEATFor Q4, we expect reported sales growth of approximately 1.5% to 2.5%
  • May 1, 2025MISSEDFor Q1, we expect reported sales growth of approximately 1%
  • Oct 31, 2025BEATFor Q3, we expect reported and organic sales growth of approximately 1 - 2%
  • Feb 12, 2026BEATWe now expect higher 2025 reported sales growth of approximately 1.5%
  • Feb 12, 2026BEATFor Q4, we expect reported sales growth of approximately 3.5%
  • Jul 31, 2026KEPTwe expect a reported sales decline of approximately 1%
23 resolved guidance promises · 79dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →